Intermittent Subcutaneous Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Pediatric Intensive Care Unit Patients.

In this cohort, bleeding events were more common than thrombotic events and occurred in 24% of patients, while venous thromboembolism developed in 11%.

These findings highlight the need for more standardized dosing strategies and further prospective evaluation to better define the safety and effectiveness of sUFH for venous thromboembolism prophylaxis in the pediatric intensive care unit.